Efficacy and Safety of Iguratimod Supplement to the Standard Immunosuppressive Regimen in Highly Mismatched Renal Transplant Recipients: A Pilot Study

Iguratimod (IGU) can mitigate the symptoms of rheumatoid arthritis through its anti-inflammatory effects. The objective of this study was to investigate the clinical efficacy and safety of IGU in highly HLA-mismatched renal transplant recipients, in combination with standard immunosuppressive regime...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jun Tao, Li Sun, Zijie Wang, Hao Chen, Zhijian Han, Hengcheng Zhang, Haiwei Yang, Zhengkai Huang, Shuang Fei, Xiaobin Ju, Ruoyun Tan, Min Gu
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/e756b7d5b8ea4e82ad4976baa6ce9473
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!